Rhinitis and Asthma in a Pregnant Patient Evaluation

Young Girl with Peanut Allergy Evaluation

Now that you have completed this activity, please provide feedback regarding its quality and the impact it will have on your practice.

Please rate your ability to perform the following objectives upon completion of this activity, with 1 = Not confident and 5 = Able to demonstrate *

	1	2	3	4	5
Learning Objective 1: Discuss the current FDA approval status of food OIT treatments	Learning Objective 1: Discuss the current FDA approval status of food OIT treatments - 1	Learning Objective 1: Discuss the current FDA approval status of food OIT treatments - 2	Learning Objective 1: Discuss the current FDA approval status of food OIT treatments - 3	Learning Objective 1: Discuss the current FDA approval status of food OIT treatments - 4	Learning Objective 1: Discuss the current FDA approval status of food OIT treatments - 5
Learning Objective 2: Summarize findings from studies regarding administration, duration, safety, efficacy, and cross-reactivity of food OIT	Learning Objective 2: Summarize findings from studies regarding administration, duration, safety, efficacy, and cross-reactivity of food OIT - 1	Learning Objective 2: Summarize findings from studies regarding administration, duration, safety, efficacy, and cross-reactivity of food OIT - 2	Learning Objective 2: Summarize findings from studies regarding administration, duration, safety, efficacy, and cross-reactivity of food OIT - 3	Learning Objective 2: Summarize findings from studies regarding administration, duration, safety, efficacy, and cross-reactivity of food OIT - 4	Learning Objective 2: Summarize findings from studies regarding administration, duration, safety, efficacy, and cross-reactivity of food OIT - 5
Learning Objective 3: Explain how desensitization is measured and how to minimize the risk of a reaction during oral immunotherapy by avoiding so called augmentation factors	Learning Objective 3: Explain how desensitization is measured and how to minimize the risk of a reaction during oral immunotherapy by avoiding so called augmentation factors - 1	Learning Objective 3: Explain how desensitization is measured and how to minimize the risk of a reaction during oral immunotherapy by avoiding so called augmentation factors - 2	Learning Objective 3: Explain how desensitization is measured and how to minimize the risk of a reaction during oral immunotherapy by avoiding so called augmentation factors - 3	Learning Objective 3: Explain how desensitization is measured and how to minimize the risk of a reaction during oral immunotherapy by avoiding so called augmentation factors - 4	Learning Objective 3: Explain how desensitization is measured and how to minimize the risk of a reaction during oral immunotherapy by avoiding so called augmentation factors - 5

Please rate the following: *

	Poor	Fair	Good	Very Good	Excellent
Quality of the content	Quality of the content - Poor	Quality of the content - Fair	Quality of the content - Good	Quality of the content - Very Good	Quality of the content - Excellent
Quality of the format	Quality of the format - Poor	Quality of the format - Fair	Quality of the format - Good	Quality of the format - Very Good	Quality of the format - Excellent
Relevance to your practice (patient care, research, teaching)	Relevance to your practice (patient care, research, teaching) - Poor	Relevance to your practice (patient care, research, teaching) - Fair	Relevance to your practice (patient care, research, teaching) - Good	Relevance to your practice (patient care, research, teaching) - Very Good	Relevance to your practice (patient care, research, teaching) - Excellent

Did you detect any commercial bias in this activity? *

Yes

No Answer

If you detected bias, please describe the biased content:

Based on knowledge and skills you gained in completing this activity, do you plan to make changes to your practice (patient care, research, or teaching)? *

Yes

No Answer

If you plan to change your practice based on what you have learned, please describe below:

If you have not made or do not plan to make changes to your practice based on what you learned by completing this activity, please indicate why. Select all that apply:

Need to learn more before I feel comfortable changing my practice

Knowledge and skills I gained did not have an immediate application

Knowledge and skills I gained reinforced my current practice behaviors

Financial limitations

Staffing limitations

Other:

If you have not made or do not plan to make changes to your practice based on what you learned by completing this activity, please indicate why. Select all that apply: Other:

After attending this activity, what do you need to learn more about to improve your practice (patient care, research, or teaching)?

Please provide any additional comments you would like to share:

Leave this field blank

AAAAI Education Center

Add to favorites link

Virtual Patient: Young Girl with Peanut Allergy

Young Girl with Peanut Allergy Evaluation

Young Girl with Peanut Allergy Patient Simulation

Young Girl with Peanut Allergy References

Commitment to Change

Young Girl with Peanut Allergy Evaluation

Credit

Certificate

You are here

Virtual Patient: Young Girl with Peanut Allergy

Young Girl with Peanut Allergy Evaluation

Young Girl with Peanut Allergy Patient Simulation

Young Girl with Peanut Allergy References

Commitment to Change

Young Girl with Peanut Allergy Evaluation

Credit

Certificate